Debra A Gordon

Title: Debra A. Gordon: Innovator in Nuclease Protection Assay Technologies

Introduction

Debra A. Gordon is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of molecular diagnostics, particularly through her innovative work on quantitative Nuclease Protection Assay (qNPA) and quantitative Nuclease Protection Sequencing (qNPS) methods. Her research has the potential to enhance the detection and sequencing of nucleic acid molecules.

Latest Patents

Debra A. Gordon holds 1 patent for her improvements in quantitative Nuclease Protection Assay (QNPA) and sequencing (QNPS). The patent details methods that utilize nuclease protection probes (NPPs) with 5'-end and/or 3'-end flanking sequences. These advancements provide a universal hybridization and/or amplification sequence, allowing for the effective sequencing or detection of target nucleic acid molecules, including those found in fixed or insoluble samples.

Career Highlights

Debra is currently associated with Htg Molecular Diagnostics, Inc., where she continues to push the boundaries of molecular diagnostics. Her work is instrumental in developing more efficient and reliable methods for nucleic acid detection, which is crucial for various applications in research and clinical settings.

Collaborations

Throughout her career, Debra has collaborated with notable colleagues, including Bruce Seligmann and Debrah Thompson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Debra A. Gordon's contributions to the field of molecular diagnostics through her innovative patent work exemplify her commitment to advancing scientific knowledge and technology. Her efforts in improving qNPA and qNPS methods are paving the way for more effective nucleic acid detection and sequencing techniques.